Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Adherium Ltd. ( (AU:ADR) ).
Adherium director George Baran has significantly increased his indirect equity stake in the company through Trudell Medical Limited following the conversion of convertible notes into fully paid ordinary shares and the receipt of additional attaching options. The transactions, completed in December 2025 at an issue price of $0.005 per share or note, saw Baran’s indirect holdings rise to 762,002,965 shares and a substantially higher number of unlisted options, while his convertible note balance fell to zero, indicating a material shift from debt-like instruments to equity that further aligns his interests with those of Adherium’s shareholders.
The most recent analyst rating on (AU:ADR) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Adherium Ltd. stock, see the AU:ADR Stock Forecast page.
More about Adherium Ltd.
Technical Sentiment Signal: Sell
Current Market Cap: A$15.33M
For a thorough assessment of ADR stock, go to TipRanks’ Stock Analysis page.